Blog Archives

PRESS RELEASE: GLNT Tackles Continuous Monitoring of Essential Tremor with Launch of Multi-Site Clinical Study

VIEW PRESS RELEASE [PDF]

April 5, 2012: Valley View, OH Great Lakes NeuroTechnologies announced today they have launched a multi-site clinical study to assess continuous monitoring of essential tremor (ET) using their Kinesia technology platform. A preliminary study published in 2011 in the journal Parkinsonism and Related Disorders demonstrated that patient-worn motion sensors could detect tremor type and quantify tremor severity during both standardized tasks and non-standardized activities of daily living performed in a laboratory.

Read more ›



PRESS RELEASE: GLNT Begins Clinical Study to Demonstrate High Sensitivity Motor Symptom Detection in Parkinson’s Disease

VIEW PRESS RELEASE [PDF]

March 23, 2012: Valley View, OH Great Lakes NeuroTechnologies announced today that they have begun a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with Parkinson’s disease (PD).

Read more ›



PRESS RELEASE: GLNT Awarded Patent for Technology to Assess Parkinson’s Disease

VIEW PRESS RELEASE [PDF]

8MAR2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have received allowance of claims from the U.S. Patent Office for an application covering their Movement Disorder Monitoring System and Method for quantitative assessment of motor symptoms associated with movement disorders.

Read more ›



Acute effects of passive leg cycling on upper extremity tremor and bradykinesia in Parkinson’s disease

A. Ridgel, M. Muller, C. Kim, E. Fickes, T. Mera
Phys Sportsmed. 2011 Sep;39(3):83-93

Read more ›



PRESS RELEASE: Great Lakes NeuroTechnologies Receives Nearly $2 Million In New Funding To Expand Home-Based Technologies For Monitoring Movement Disorders

VIEW PRESS RELEASE [PDF]

01 SEPT 2011: Cleveland OH – Great Lakes NeuroTechnologies was recently awarded two NIH SBIR grants: $1.7 million in Phase II funding from the National Institute on Aging to develop ETSense ™, an adaptive, portable essential tremor (ET) monitor and $256,000 in Phase I funding from the National Institute of Neurological Disorders and Stroke to develop Kinesia-HS™,

Read more ›



PRESS RELEASE: The University of Rochester and Great Lakes NeuroTechnologies launch new clinical study to develop ambulatory dyskinesia assessment system

VIEW PRESS RELEASE [PDF]

Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology will be used in a clinical study to capture and quantify dyskinesias (involuntary, irregular movements) caused by Parkinson’s disease (PD) medication. PD motor symptoms including tremor and bradykinesia are typically treated with levodopa.

Read more ›



PRESS RELEASE: Great Lakes NeuroTechnologies’ KinetiSense technology used in Parkinson’s disease gait and balance study

VIEW PRESS RELEASE [PDF]

Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology was used in a clinical study to capture and quantify the effect of Deep Brain Stimulation (DBS) on gait and balance impairment in Parkinson’s disease (PD).

Read more ›



Logarithmic Relationship Between Head Tremor and 5-Point Tremor Rating

Rodger Elble, MD PhD, Helge Hellriegel, MD, Jan Raethjen, MD and Günther Deuschl, MD

International Congress Of Parkinson’s Disease And Movement Disorders, Toronto, CA 2011

Read more ›



PRESS RELEASE: CLEVEMED ASSISTS AMERICAN MEDICAL ASSOCIATION IN RELEASE OF CPT CODE FOR RECORDING PHYSIOLOGIC TREMOR

VIEW PRESS RELEASE [PDF]

CLEVELAND, OHIO (April 25, 2009) – The American Medical Association (AMA) CPT® Editorial Panel approved the release of Category III CPT code 0199T for physiologic recording of tremor using accelerometer(s) and gyroscope(s), (including frequency and amplitude) including interpretation and report.

Read more ›



Clinically Deployable Kinesia Technology for Automated Tremor Assessment

J. Giuffrida, D. Riley, B. Maddux, D. Heldman
Mov Disord. 2009 Apr 15;24(5):723-30

Read more ›



Top